Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
F 83.73 -0.33% -0.28
NVS closed down 0.33 percent on Monday, March 8, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NVS trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -0.33%
Stochastic Reached Oversold Weakness -0.33%
Lower Bollinger Band Touch Weakness -0.33%
Oversold Stochastic Weakness -0.33%
New Downtrend Bearish 0.28%
Expansion Breakdown Bearish Swing Setup 0.28%
Below Lower BB Weakness 0.28%
Gapped Down Weakness 0.28%
Older End-of-Day Signals for NVS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Novartis AG Description

Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biotechnology Pharmaceutical Industry Eye Drugs Infectious Diseases Pharmaceuticals Pharmacy Medication Neuroscience Antibiotic Animal Health Ophthalmic Ophthalmology Eyewear Dosage Forms Healthcare Products Healthcare Product Prescription Drug Metabolism Disposable Products Lenses Molecular Diagnostics Disposable Product Active Pharmaceutical Ingredients Antibiotics Blood Test Primary Care Contact Lens Contact Lenses Eye Care Over The Counter Drug Diagnostics Products Intraocular Lens Surgical Equipment Lens Care Products Veterinary Products

Is NVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 98.52
52 Week Low 69.18
Average Volume 2,001,001
200-Day Moving Average 87.95
50-Day Moving Average 91.33
20-Day Moving Average 88.33
10-Day Moving Average 86.10
Average True Range 1.56
ADX 29.46
+DI 15.97
-DI 42.52
Chandelier Exit (Long, 3 ATRs ) 87.68
Chandelier Exit (Short, 3 ATRs ) 86.97
Upper Bollinger Band 93.76
Lower Bollinger Band 82.89
Percent B (%b) 0.08
BandWidth 12.30
MACD Line -1.94
MACD Signal Line -1.54
MACD Histogram -0.3992
Fundamentals Value
Market Cap 190.44 Billion
Num Shares 2.27 Billion
EPS 3.09
Price-to-Earnings (P/E) Ratio 27.12
Price-to-Sales 4.14
Price-to-Book 3.72
PEG Ratio 2.78
Dividend 3.09
Dividend Yield 3.69%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 85.41
Resistance 3 (R3) 85.56 85.15 85.13
Resistance 2 (R2) 85.15 84.72 85.07 85.03
Resistance 1 (R1) 84.44 84.46 84.23 84.29 84.94
Pivot Point 84.03 84.03 83.93 83.95 84.03
Support 1 (S1) 83.32 83.60 83.12 83.17 82.52
Support 2 (S2) 82.91 83.34 82.84 82.43
Support 3 (S3) 82.20 82.91 82.33
Support 4 (S4) 82.05